Diseases [C] » Endocrine System Diseases
Description
Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. MeSH
Hierarchy View
Subtype Terms (11)
Adrenal Gland Diseases
14 drugs (8 approved, 6 experimental)
Bone Diseases, Endocrine
4 drugs (3 approved, 1 experimental)
Diabetes Mellitus
843 drugs (373 approved, 470 experimental)
Dwarfism
5 drugs (4 approved, 1 experimental)
Endocrine Gland Neoplasms
16 drugs (11 approved, 5 experimental)
Gonadal Disorders
14 drugs (11 approved, 3 experimental)
Parathyroid Diseases
19 drugs (16 approved, 3 experimental)
Pituitary Diseases
15 drugs (12 approved, 3 experimental)
Polyendocrinopathies, Autoimmune
1 approved drug
Thyroid Diseases
38 drugs (29 approved, 9 experimental)
Phase 4 Indicated Drugs (6)
Phase 3 Indicated Drugs (18)
Phase 2 Indicated Drugs (20)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (13)
Organization Involved with Phase 4 Indications (50)
Organization Involved with Phase 3 Indications (24)
Organization Involved with Phase 2 Indications (37)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.